855 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceutical Industries (TEVA) Q4 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2019/02/14/teva-pharmaceutical-industries-teva-q4-2018-earnin.aspx?source=iedfolrf0000001 Feb 14, 2019 - TEVA earnings call for the period ending December 31, 2018.
Credit Suisse Stays Sidelined On Teva: 'Our Growth Expectations Are Below That Of The Company' http://feeds.benzinga.com/~r/benzinga/~3/DqC3wX2BtY8/credit-suisse-stays-sidelined-on-teva-our-growth-expect Feb 14, 2019 -

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported disappointing fourth-quarter earnings Wednesday before the market open, sending its shares down about 8 percent.

Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down http://www.zacks.com/stock/news/354559/teva-teva-q4-earnings-miss19-view-weak-shares-down?cid=CS-ZC-FT-354559 Feb 14, 2019 - Teva's (TEVA) fourth-quarter earnings miss estimates while sales marginally beat expectations. Guidance for 2019 is lower than expected.
Why Teva Pharmaceutical Industries, McDermott International, and Groupon Slumped Today https://www.fool.com/investing/2019/02/13/why-teva-pharmaceutical-industries-mcdermott-inter.aspx?source=iedfolrf0000001 Feb 13, 2019 - Find out what made these stocks lose ground despite a good session for the markets.
Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report http://www.zacks.com/stock/news/354373/key-takeaways-from-eli-lillys-lly-q4-earnings-report?cid=CS-ZC-FT-354373 Feb 13, 2019 - Here are the key takeaways from Eli Lilly's (LLY) fourth-quarter earnings conference call.
Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4240605-teva-pharmaceutical-industries-ltd-teva-ceo-kare-schultz-q4-2018-results-earnings-call?source=feed_tag_israel Feb 13, 2019 - Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Q4 2018 Earnings Conference Call February 13, 2019, 08:00 ET Company Participants Kevin Mannix - Head, Global IR & VP Kare Schultz - President, CEO &
Stocks making the biggest moves midday: Teva Pharmaceuticals, Hilton, Groupon & more https://www.cnbc.com/2019/02/13/stocks-making-the-biggest-moves-midday-teva-pharmaceuticals-hilton-groupon--more.html Feb 13, 2019 - Names on the move ahead of the open.
Teva's Schultz ok with current U.S. payer coverage for migraine med Ajovy https://seekingalpha.com/news/3432751-tevas-schultz-ok-current-u-s-payer-coverage-migraine-med-ajovy?source=feed_news_all Feb 13, 2019 - Teva Pharmaceutical Industries (TEVA -7.8%) chief Kåre Schultz told Reuters that he is "content" with 2/3 of U.S. insurers covering Ajovy (fremanezumab-vfrm) because he does not want to be ove
Stock Market Update: FAANG Stocks Trade Mixed; Teva Falls on Earnings Report http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=SI20190213095515 Feb 13, 2019 - The S&P 500 currently trades higher by 0.5%, and the Russell 2000 trades higher...
Teva Pharmaceutical Industries Limited 2018 Q4 - Results - Earnings Call Slides https://seekingalpha.com/article/4240536-teva-pharmaceutical-industries-limited-2018-q4-results-earnings-call-slides?source=feed_tag_israel Feb 13, 2019 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2018 Q4 earnings call.

Pages: 1...678910111213141516...86

<<<Page 11>